Disease

---

Cohen, F., Brooks, C. V., Sun, D., Buse, D. C., Reed, M. L., Fanning, K. M., & Lipton, R. B. (2025). Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings. Headache: The Journal of Head and Face Pain, 65(1), 11-13.

Lanteri-Minet, M., Leroux, E., Katsarava, Z., Lipton, R. B., Sakai, F., Matharu, M., ... & Buse, D. C. (2024). Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes-International (CaMEO-I) study. The Journal of Headache and Pain, 25(1), 134.

Katsarava, Z., Buse, D. C., Leroux, E., Lanteri-Minet, M., Sakai, F., Matharu, M. S., ... & Lipton, R. B. (2024). Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes-International (CaMEO-I) Study. Cephalalgia, 44(8), 03331024241274343.

Buse, D. C., Sakai, F., Matharu, M., Reed, M. L., Fanning, K., Dabruzzo, B., & Lipton, R. B. (2024). Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study. Headache: The Journal of Head and Face Pain, 64(5), 469-481.

Cohen, F., Brooks, C. V., Sun, D., Buse, D. C., Reed, M. L., Fanning, K. M., & Lipton, R. B. (2024). Prevalence and burden of migraine in the United States: a systematic review. Headache: The Journal of Head and Face Pain, 64(5), 516-532.

Bavikatte, G., Esquenazi, A., Dimyan, M. A., Dashtipour, K., Feng, W., Mayadev, A., Fanning, K., Musacchio, T., Zuzek, A., & Francisco, G. E. (2024). Safety and real-world dosing of onabotulinumtoxinA for the treatment of adult spasticity: Post hoc analysis of the Adult Spasticity International Registry study. American Journal of Physical Medicine & Rehabilitation, 103(7), 580-587.

Lipton, R. B., Lanteri-Minet, M., Leroux, E., Manack Adams, A., Contreras-De Lama, J., Reed, M. L., Fanning, K.M., & Buse, D. C. (2023). Pre-and post-headache phases of migraine: multi-country results from the CaMEO-International Study. The Journal of Headache and Pain, 24(1), 151.

Lipton, R. B., Pozo‐Rosich, P., Orr, S. L., Reed, M. L., Fanning, K. M., Dabruzzo, B., & Buse, D. C. (2023). Impact of monthly headache days on migraine‐related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. Headache: The Journal of Head and Face Pain, 63(10), 1448-1457.

Adams, A. M., Buse, D. C., Leroux, E., Lanteri-Minet, M., Sakai, F., Matharu, M. S., ... & Lipton, R. B. (2023). Chronic Migraine Epidemiology and Outcomes-International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care. Cephalalgia, 43(6), 03331024231180611.

Buse, D. C., Nahas, S. J., Armand, C. E., Reed, M. L., Fanning, K. M., Adams, A. M., & Lipton, R. B. (2023). Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Journal of Occupational and Environmental Medicine, 65(4), e261.

Ezzati, A., Fanning, K. M., Reed, M. L., & Lipton, R. B. (2023). Predictors of treatment‐response to caffeine combination products, acetaminophen, acetylsalicylic acid (aspirin), and nonsteroidal anti‐inflammatory drugs in acute treatment of episodic migraine. Headache: The Journal of Head and Face Pain, 63(3), 342-352.

Ezzati, A., Buse, D. C., Fanning, K. M., Reed, M. L., Martin, V. T., & Lipton, R. B. (2022). Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Clinical Neurology and Neurosurgery, 223, 107511.

Ezzati, A., Fanning, K. M., Buse, D. C., Pavlovic, J. M., Armand, C. E., Reed, M. L., ... & Lipton, R. B. (2022). Predictive models for determining treatment response to nonprescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention Study. Headache: The Journal of Head and Face Pain, 62(6), 755-765.

Lipton, R. B., Buse, D. C., Dodick, D. W., Schwedt, T. J., Singh, P., Munjal, S., ... & Reed, M. L. (2021). Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study. Headache: The Journal of Head and Face Pain, 61(1), 103-116.

Schwedt, T. J., Buse, D. C., Argoff, C. E., Reed, M. L., Fanning, K. M., Hussar, C. R., ... & Lipton, R. B. (2021). Medication overuse and headache burden: results from the CaMEO study. Neurology: Clinical Practice, 11(3), 216-226.

Buse, D. C., Armand, C. E., Charleston IV, L., Reed, M. L., Fanning, K. M., Adams, A. M., & Lipton, R. B. (2021). Barriers to care in episodic and chronic migraine: Results from the Chronic
Migraine Epidemiology and Outcomes Study. Headache: The Journal of Head and Face Pain,
61(4), 628-641

Munjal, S., Singh, P., Reed, M. L., Fanning, K., Schwedt, T. J., Dodick, D. W., ... & Lipton, R. B. (2020). Most bothersome symptom in persons with migraine: results from the Migraine in America Symptoms and Treatment (MAST) study. Headache: The Journal of Head and Face Pain, 60(2), 416-429.

Buse, D. C., Reed, M. L., Fanning, K. M., Bostic, R., Dodick, D. W., Schwedt, T. J., ... & Lipton, R. B. (2020). Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. The journal of headache and pain, 21(1), 1-16.

Lipton, R. B., Buse, D. C., Friedman, B. W., Feder, L., Adams, A. M., Fanning, K. M., &
Schwedt, T. J. (2020). Characterizing opioid use in a US population with migraine: results from
the CaMEO study. Neurology, 95(5), e457-e468.

Hutchinson, S., Lipton, R. B., Ailani, J., Reed, M. L., Fanning, K. M., Adams, A. M., & Buse, D.C. (2020, April). Characterization of acute prescription migraine medication use: results from the CaMEO study. In Mayo Clinic Proceedings (Vol. 95, No. 4, pp. 709-718). Elsevier.

Lipton, R. B., Seng, E. K., Chu, M. K., Reed, M. L., Fanning, K. M., Adams, A. M., & Buse, D. C. (2020). The effect of psychiatric comorbidities on headache‐related disability in migraine: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. Headache: The Journal of Head and Face Pain, 60(8), 1683-1696.

Buse, D. C., Reed, M. L., Fanning, K. M., Bostic, R. C., & Lipton, R. B. (2020). Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache: The Journal of Head and Face Pain, 60(10), 2340-2356.

Lipton, R. B., Munjal, S., Buse, D. C., Alam, A., Fanning, K. M., Reed, M. L., & Dodick, D. W. (2019). Unmet acute treatment needs from the 2017 Migraine in America Symptoms and
Treatment Study. Headache: The Journal of Head and Face Pain, 59(8), 1310-1323.

Buse, D. C., Fanning, K. M., Reed, M. L., Murray, S., Dumas, P. K., Adams, A. M., & Lipton, R.B. (2019). Life with migraine: effects on relationships, career, and finances from the chronic
migraine epidemiology and outcomes (CaMEO) study. Headache: The Journal of Head and
Face Pain, 59(8), 1286-1299.

Buse, D. C., Rains, J. C., Pavlovic, J. M., Fanning, K. M., Reed, M. L., Manack Adams, A., &
Lipton, R. B. (2019). Sleep disorders among people with migraine: results from the chronic
migraine epidemiology and outcomes (CaMEO) study. Headache: The Journal of Head and
Face Pain, 59(1), 32-45.

Lipton, R. B., Fanning, K. M., Buse, D. C., Martin, V. T., Hohaia, L. B., Adams, A. M., &
Goadsby, P. J. (2019). Migraine progression in subgroups of migraine based on comorbidities:
results of the CaMEO study. Neurology, 93(24), e2224-e2236.

Lipton, R. B., Hutchinson, S., Ailani, J., Reed, M. L., Fanning, K. M., Manack Adams, A., &
Buse, D. C. (2019). Discontinuation of acute prescription medication for migraine: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache: The Journal of Head and Face Pain, 59(10), 1762-1772.

Dodick, D. W., Reed, M. L., Fanning, K. M., Munjal, S., Alam, A., Buse, D. C., & Lipton, R. B. (2019). Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study. Cephalalgia, 39(7), 873-882.

Scher, A. I., Wang, S. J., Katsarava, Z., Buse, D. C., Fanning, K. M., Adams, A. M., & Lipton, R.B. (2019). Epidemiology of migraine in men: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Cephalalgia, 39(2), 296-305.

Schwedt, T. J., Alam, A., Reed, M. L., Fanning, K. M., Munjal, S., Buse, D. C., & Lipton, R. B. (2018). Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. The journal of headache and pain, 19(1), 1-9.

Lipton, R. B., Munjal, S., Alam, A., Buse, D. C., Fanning, K. M., Reed, M. L., & Dodick, D. W. (2018). Migraine in America Symptoms and Treatment (MAST) study: baseline study methods, treatment patterns, and gender differences. Headache: The Journal of Head and Face Pain, 58(9), 1408-1426.

Lipton, R. B., Fanning, K. M., Buse, D. C., Martin, V. T., Reed, M. L., Manack Adams, A., & Goadsby, P. J. (2018). Identifying natural subgroups of migraine based on comorbidity and concomitant condition profiles: results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache: The Journal of Head and Face Pain, 58(7), 933-947.

Buse, D. C., Powers, S. W., Gelfand, A. A., VanderPluym, J. H., Fanning, K. M., Reed, M. L., & Lipton, R. B. (2018). Adolescent perspectives on the burden of a parent's migraine: Results from the CaMEO study. Headache: The Journal of Head and Face Pain, 58(4), 512-524.

Scher, A. I., Buse, D. C., Fanning, K. M., Kelly, A. M., Franznick, D. A., Adams, A. M., & Lipton, R. B. (2017). Comorbid pain and migraine chronicity: the chronic migraine epidemiology and outcomes study. Neurology, 89(5), 461-468.

Lipton, R. B., Buse, D. C., Adams, A. M., Varon, S. F., Fanning, K. M., & Reed, M. L. (2017). Family impact of migraine: development of the impact of migraine on partners and adolescent children (IMPAC) scale. Headache: The Journal of Head and Face Pain, 57(4), 570-585.

Lipton, R. B., Munjal, S., Buse, D. C., Bennett, A., Fanning, K. M., Burstein, R., & Reed, M. L. (2017). Allodynia is associated with initial and sustained response to acute migraine treatment: results from the American Migraine Prevalence and Prevention Study. Headache: The Journal of Head and Face Pain, 57(7), 1026-1040.

Lipton, R. B., Reed, M. L., Kurth, T., Fanning, K. M., & Buse, D. C. (2017). Framingham‐based cardiovascular risk estimates among people with episodic migraine in the US population: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache: The Journal of Head and Face Pain, 57(10), 1507-1521.

Buse, D. C., Reed, M. L., Fanning, K. M., Kurth, T., & Lipton, R. B. (2017). Cardiovascular events, conditions, and procedures among people with episodic migraine in the US population: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache: The Journal of Head and Face Pain, 57(1), 31-44.

Lipton, R., Chu, M. K., Seng, E., Reed, M., Fanning, K., Adams, A. M., & Buse, D. (2017). The effect of psychiatric comorbidities on headache-related disability in migraine: results from the chronic migraine epidemiology and outcomes (CaMEO) study Headache: The Journal of Head and Face Pain, 60(10), 1683-1696.

Lipton, R. B., Munjal, S., Buse, D. C., Fanning, K. M., Bennett, A., & Reed, M. L. (2016). Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Headache: The Journal of Head and Face Pain, 56(10), 1635-1648.

Martin, V. T., Pavlovic, J., Fanning, K. M., Buse, D. C., Reed, M. L., & Lipton, R. B. (2016). Perimenopause and menopause are associated with high frequency headache in women with migraine: results of the American migraine prevalence and prevention study. Headache: The Journal of Head and Face Pain, 56(2), 292-305.

Martin, V. T., Fanning, K. M., Serrano, D., Buse, D. C., Reed, M. L., & Lipton, R. B. (2016). Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study. Headache: The Journal of Head and Face Pain, 56(1), 118-131.

Lipton, R. B., Manack Adams, A., Buse, D. C., Fanning, K. M., & Reed, M. L. (2016). A comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) study and American Migraine Prevalence and Prevention (AMPP) study: demographics and headache‐related disability. Headache: The Journal of Head and Face Pain, 56(8), 1280-1289.

Dodick, D. W., Loder, E. W., Manack Adams, A., Buse, D. C., Fanning, K. M., Reed, M. L., & Lipton, R. B. (2016). Assessing barriers to chronic migraine consultation, diagnosis, and treatment: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache: The Journal of Head and Face Pain, 56(5), 821-834.

Buse, D. C., Scher, A. I., Dodick, D. W., Reed, M. L., Fanning, K. M., Adams, A. M., & Lipton, R. B. (2016). Impact of migraine on the family: perspectives of people with migraine and their spouse/domestic partner in the CaMEO study. In Mayo Clinic Proceedings (Vol. 91, No. 5, pp. 596-611). Elsevier.

Lipton, R. B., Fanning, K. M., Serrano, D., Reed, M. L., Cady, R., & Buse, D. C. (2015). Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology, 84(7), 688-695.

Tietjen, G. E., Buse, D. C., Fanning, K. M., Serrano, D., Reed, M. L., & Lipton, R. B. (2015). Recalled maltreatment, migraine, and tension-type headache: results of the AMPP study. Neurology, 84(2), 132-140.

Reed, M. L., Fanning, K. M., Serrano, D., Buse, D. C., & Lipton, R. B. (2015). Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results. Headache: the journal of head and face pain, 55(1), 76-87.

Adams, A. M., Serrano, D., Buse, D. C., Reed, M. L., Marske, V., Fanning, K. M., & Lipton, R. B. (2015). The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia, 35(7), 563-578.

Martin, V. T., Fanning, K. M., Serrano, D., Buse, D. C., Reed, M. L., Bernstein, J. A., & Lipton, R. B. (2014). Chronic rhinitis and its association with headache frequency and disability in persons with migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Cephalalgia, 34(5), 336-348.

Holland, S., Fanning, K. M., Serrano, D., Buse, D. C., Reed, M. L., & Lipton, R. B. (2013). Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Journal of the neurological sciences, 326(1-2), 10-17.

Lipton RB, Buse DC, Saiers J, Fanning KM, Serrano D, Reed ML. (2013) Frequency and Burden of Headache-Related Nausea: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Headache, 53, 93-103.

Lipton, R. B., Serrano, D., Holland, S., Fanning, K. M., Reed, M. L., & Buse, D. C. (2013). Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features. Headache: The Journal of Head and Face Pain, 53(1), 81-92.

Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB. (2012) Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache, 53(8), 1278-1299.

Buse DC, Manack AN, Fanning KM, Serrano D. (2012) Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study. Headache, 52:1456-1470.

Ettinger, A. B., Ottman, R., Lipton, R. B., Cramer, J. A., Fanning, K. M., & Reed, M. L. (2015). Attention‐deficit/hyperactivity disorder symptoms in adults with self‐reported epilepsy: Results from a national epidemiologic survey of epilepsy. Epilepsia, 56(2), 218-224.

Lau C, Ettinger AB, Hamberger S, Fanning K, Reed, ML. (2012) Do Mood Instability Symptoms in Epilepsy Represent Formal Bipolar Disorder? Epilepsia, 53(2) :e37-e40.

Ettinger AB, Reed ML, Cramer JA, for the Epilepsy Impact Project Group (2004). Depression and Comorbidity in Community-based Patients with Epilepsy or Asthma. Neurology, 63:1008-1014.

Cramer JA, Blum D, Reed ML, Fanning K, (2004) for the Epilepsy Impact Project Group. The Influence of Comorbid Depression on Quality of Life for People with Epilepsy. Epilepsy & Behavior, 4: 515-521.

Cramer JA, Blum D, Fanning K, Reed ML, (2004) for the Epilepsy Impact Project Group. The Impact of Comorbid Depression on Health Resource Utilization in a Community Sample of People with Epilepsy. Epilepsy& Behavior, 5:3:337-342.

Cramer JA, Blum D, Reed ML, Fanning K. (2003) The Influence of Comorbid Depression on Seizure Severity. Epilepsia, 44:1578-1584.

Benner, J. S., Nichol, M. B., Rovner, E. S., Jumadilova, Z., Alvir, J., Hussein, M., Fanning, K.M., Trocio, J.N., & Brubaker, L. (2010). Patient‐reported reasons for discontinuing overactive bladder medication. BJU international, 105(9), 1276-1282.

Brubaker, L., Fanning, K., Goldberg, E. L., Benner, J. S., Trocio, J. N., Bavendam, T., & Jumadilova, Z. (2010). Predictors of discontinuing overactive bladder medications. BJU international, 105(9), 1283-1290.

Benner, J. S., Becker, R., Fanning, K., Jumadilova, Z., Bavendam, T., Brubaker, L., & OAB Medication Use Study Steering Committee. (2009). Bother related to bladder control and health care seeking behavior in adults in the United States. The Journal of urology, 181(6), 2591-2598.

Fuhlbrigge, A., Reed, M. L., Stempel, D. A., Ortega, H. O., Fanning, K., & Stanford, R. H. (2009). The status of asthma control in the US adult population. In Allergy and Asthma Proceedings (Vol. 30, No. 5, pp. 529-533). OceanSide Publications, Inc.

Lau, C., Ettinger, A. B., Hamberger, S., Fanning, K., & Reed, M. L. (2012). Do mood instability symptoms in epilepsy represent formal bipolar disorder? Epilepsia, 53(2), e37-e40.

Weisbrot, D. M., Carlson, G. A., Ettinger, A. B., Reed, M. L., Fanning, K. M., & Bostic, R. C. (2023). Psychiatric characteristics of students who make threats toward others at school. Journal of the American Academy of Child & Adolescent Psychiatry, 62(7), 764-776.

Esquenazi, A., Francisco, G. E., Feng, W., Baricich, A., Gallien, P., Fanning, K., ... & Wittenberg, G. F. (2021). Real-world adherence to onabotulinumtoxinA treatment for spasticity: insights from the ASPIRE study. Archives of Physical Medicine and Rehabilitation, 102(11), 2172-2184.

Esquenazi, A., Feng, W., Wittenberg, G., Gallien, P., Baricich, A., Fanning, K., ... & Bandari, D. (2021). Consistent Dosing Over Time And Within Treatment Interval Groups With Onabotulinumtoxina: Analysis from the Adult Spasticity International Registry (ASPIRE). Archives of Physical Medicine and Rehabilitation, 102(10), e48.